首页 | 官方网站   微博 | 高级检索  
     

HPLC-ESI-Q-TOF MS/MS分析肉苁蓉拟雌激素活性部位入血成分
引用本文:李文兰,白晶,臧宝珊,刘梦娇,许颖,陈嫱,季宇彬.HPLC-ESI-Q-TOF MS/MS分析肉苁蓉拟雌激素活性部位入血成分[J].质谱学报,2015,36(3):223-228.
作者姓名:李文兰  白晶  臧宝珊  刘梦娇  许颖  陈嫱  季宇彬
作者单位:1.哈尔滨商业大学生命科学与环境科学研究中心,黑龙江 哈尔滨150076;2.国家教育部抗肿瘤天然药物工程研究中心,黑龙江 哈尔滨150076
基金项目:国家自然科学基金(81073015);哈尔滨市科技创新人才研究专项资金(2011RFXXS069)资助
摘    要:为深入研究肉苁蓉(Cistanche deserticola Ma.)活性部位体内作用的物质基础,应用高效液相色谱-四极杆飞行时间质谱(HPLC-Q-TOF MS)技术对肉苁蓉拟雌激素活性部位入血成分进行分析,并与空白血清、肉苁蓉拟雌激素活性部位和对照品之间的色谱图和质谱碎片信息进行对比,共鉴别出13个化学成分,其中包括6个药材原型:京尼平苷酸、红景天苷、肉苁蓉苷A、松果菊苷、毛蕊花糖苷,肉苁蓉苷D;7个代谢成分:3,4-二羟基苯乙醇苷、甲基化毛蕊花糖苷、乙酰化肉苁蓉苷G、3,4-二羟基苯乙醇、乙酰基管花苷B、肉苁蓉苷B葡萄糖醛酸代谢物、甲基化3,4-二羟基苯乙醇苷。该方法可为进一步研究肉苁蓉药理活性和作用机理提供理论支持。

关 键 词:肉苁蓉  含药血清  拟雌激素活性  高效液相色谱-四极杆飞行时间质谱(HPLC-Q-TOF  MS)  

Analysis of Absorbed Components in Rat Plasma after Oral Administration of Quasi Estrogen Fraction of Cistanche by HPLC-ESI-Q-TOF MS/MS
LI Wen-lan;BAI Jing;ZANG Bao-shan;LIU Meng-jiao;XU Ying;CHEN Qiang;JI Yu-bin.Analysis of Absorbed Components in Rat Plasma after Oral Administration of Quasi Estrogen Fraction of Cistanche by HPLC-ESI-Q-TOF MS/MS[J].Journal of Chinese Mass Spectrometry Society,2015,36(3):223-228.
Authors:LI Wen-lan;BAI Jing;ZANG Bao-shan;LIU Meng-jiao;XU Ying;CHEN Qiang;JI Yu-bin
Affiliation:1.Center of Research on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, China; 2.Engineering Research Center of Natural Antineoplastic Drugs, Ministry of Education, Harbin 150076, China
Abstract:To analyze and identify the constituents in rat plasma after oral administration of the active fraction of cistanche, the components in rat plasma were detected by high performance liquid chromatography-electrospray ionization-quadrupole-time of flight-mass spectrometry (HPLC-Q-TOF MS). Structures of the components were elucidated by comparing their retention times and MS/MS spectra with those of reference compounds and reported data in the literatures. 13 chemical compositions are identified, including 6 prototype components, such as Geniposidic acid, Salidroside, Cistanoside A, Echinacoside, Acteoside, Cistanoside D, 7 metabolites components, such as 3,4-Dihydroxyphenylethanol glycosides, methylation acteoside, acetylation Cistanoside G, 3,4-Dihydroxyphenylethanol, acetyl tubuloside B, Cistanoside B glucuronide metabolite and methylation-3,4 Dihydroxyphenylethanol. The results can provide essential data for illuminate the therapeutic basis of quasi estrogen regulation activity of cistanche.
Keywords:cistanche  serum containing drug  quasi estrogen  high performance liquid chromatography-electrospray ionization-quadrupole-time of flight-mass spectrometry (HPLC-Q-TOF MS)  
本文献已被 CNKI 等数据库收录!
点击此处可从《质谱学报》浏览原始摘要信息
点击此处可从《质谱学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号